Correlation Between Summit Therapeutics and Zumiez
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Zumiez at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Zumiez into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and Zumiez Inc, you can compare the effects of market volatilities on Summit Therapeutics and Zumiez and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Zumiez. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Zumiez.
Diversification Opportunities for Summit Therapeutics and Zumiez
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Summit and Zumiez is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Zumiez Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zumiez Inc and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Zumiez. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zumiez Inc has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Zumiez go up and down completely randomly.
Pair Corralation between Summit Therapeutics and Zumiez
Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 1.42 times more return on investment than Zumiez. However, Summit Therapeutics is 1.42 times more volatile than Zumiez Inc. It trades about -0.03 of its potential returns per unit of risk. Zumiez Inc is currently generating about -0.05 per unit of risk. If you would invest 2,191 in Summit Therapeutics PLC on September 21, 2024 and sell it today you would lose (351.00) from holding Summit Therapeutics PLC or give up 16.02% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Summit Therapeutics PLC vs. Zumiez Inc
Performance |
Timeline |
Summit Therapeutics PLC |
Zumiez Inc |
Summit Therapeutics and Zumiez Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Summit Therapeutics and Zumiez
The main advantage of trading using opposite Summit Therapeutics and Zumiez positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Zumiez can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zumiez will offset losses from the drop in Zumiez's long position.Summit Therapeutics vs. Nkarta Inc | Summit Therapeutics vs. Cullinan Oncology LLC | Summit Therapeutics vs. Kezar Life Sciences | Summit Therapeutics vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |